Vivos Inc (RDGL) financial statements (2021 and earlier)

Company profile

Business Address 719 JADWIN AVENUE
RICHLAND, WA 99352
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1000000
Cash and cash equivalents1000000
Prepaid expense0000000
Total current assets:1000000
Noncurrent Assets
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Other undisclosed noncurrent assets(0)(0)(0)(0)(0)(0)(0)
TOTAL ASSETS:1000000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0001111
Employee-related liabilities0000000
Interest and dividends payable0000000
Other undisclosed accounts payable and accrued liabilities0000001
Debt0000000
Due to related parties0000000
Other undisclosed current liabilities0001100
Total current liabilities:1111211
Noncurrent Liabilities
Total liabilities:1111211
Stockholders' equity
Stockholders' equity attributable to parent, including:0(1)(1)(1)(1)(1)(1)
Common stock0000000
Additional paid in capital65636362626161
Accumulated deficit(75)(74)(74)(74)(74)(73)(72)
Other undisclosed stockholders' equity attributable to parent10101011101010
Total stockholders' equity:0(1)(1)(1)(1)(1)(1)
TOTAL LIABILITIES AND EQUITY:1000000

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues 00 00 
Other income  0    
Other undisclosed gross profit(0)   (0)  
Gross profit:(0)00 (0)0 
Operating expenses(0)(0)(0)(0)(0)(1)(0)
Other undisclosed operating loss  (0)    
Operating loss:(0)(0)(0)(0)(0)(1)(0)
Nonoperating expense(0)(0)(0)(0)(0)(0)(0)
Interest and debt expense(0)(0)(0)(0)0(0)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0000(0)00
Net loss available to common stockholders, diluted:(0)(0)(0)(0)(1)(1)(0)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(0)(0)(0)(0)(1)(1)(0)
Comprehensive loss, net of tax, attributable to parent:(0)(0)(0)(0)(1)(1)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: